AI Pharmaceutical Company Galixir Completes Two Financing Rounds, Raising Tens of Millions of Dollars
AI pharmaceutical company Galixir announced on Dec. 29 the completion of its latest two financing rounds, the Series A and Series A+, together worth tens of millions of dollars.
The Series A and A+ rounds, whose volume of funds has not been disclosed perspectively, are invested by ventures including Red Point, Gaorong Capital, Bertelsmann Asia Investme…
Keep reading with a 7-day free trial
Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.